Evidence map›Paper›PMID 25178815›Full record

ArticlePsychopharmacology2015

Effects of buprenorphine on behavioral tests for antidepressant and anxiolytic drugs in mice.

Edgardo Falcon, Kaitlyn Maier, Shivon A Robinson, Tiffany E Hill-Smith, Irwin Lucki

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Psychopharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02659787 (Effects of Buprenorphine on Mood in Adults With a Range of Depressive Symptomatology), which is not on this map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02659787 nacompletednot on this mapstarted 2016, after this paper: background citation

Effects of Buprenorphine on Mood in Adults With a Range of Depressive Symptomatology

TypeinterventionalSponsorUniversity of ChicagoRan2016 to 2017Enrolled38ConditionsDepressionArms0.2mg Buprenorphine, Placebo
3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 82 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. The opioid system in depression.Neuroscience and biobehavioral reviews · 2022
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. The Role of Opiates in Social Pain and Suicidal Behavior.Current topics in behavioral neurosciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Edgardo FalconDepartment of Psychiatry, University of Pennsylvania, 125 South 31st Street, Room 2204, Philadelphia, PA, 19104-3403, USA.
Kaitlyn Maier
Shivon A Robinson
Tiffany E Hill-Smith
Irwin Lucki
University of Pennsylvania · US

Funding

Training in Sleep & Sleep DisordersT32HL007953 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI David Menassah Raizen, AMY M SAWYER · 2000 to 2026
$10.6M
TRAINING PROGRAM IN NEUROPSYCHOPHARMACOLOGY-PREDOCTORALT32MH014654 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI BERRETTINI, WADE H · 1985 to 2021
$5.0M
Buprenorphine for Depression and AnxietyR01MH092412 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI LUCKI, IRWIN · 2012 to 2016
$2.0M
NHLBI NIH HHS T32 HL007953NIMH NIH HHS R01 MH092412NIMH NIH HHS R01 MH92412NIMH NIH HHS T32 MH014654NIMH NIH HHS T32 MH14654
6 · The paper itself

Abstract

rationaleBuprenorphine (BPN) has been shown to rapidly improve mood in treatment-resistant depressed patients in small clinical studies. However, BPN's effects in preclinical tests for mood and antidepressant efficacy are largely unexplored.

objectiveThe current study examined the effects of BPN in the forced swim test (FST) and novelty-induced hypophagia (NIH) test as measures of antidepressant and anxiolytic-like effects in C57BL/6 J mice. Microdialysis was used to measure whether BPN engaged kappa-opioid receptor (KORs) in the nucleus accumbens shell (NAcSh) at a behaviorally active dose (0.25 mg/kg).

methodsBPN was tested in the FST at both 30 min and 24 h post-administration. Also measured in the FST at 24 h post-administration were the KOR antagonist norbinaltorphimine (nor-BNI), the MOR agonist morphine and the reference antidepressant desipramine. The anxiolytic effects of BPN were examined in the NIH test 24 h after treatment. The effects of acute injection of BPN and the KOR agonist U50,488 were measured on extracellular dopamine (DA) levels in the NAcSh.

resultsBPN produced significant reductions in FST immobility without changing locomotor activity and reduced approach latencies in the novel environment of the NIH test when tested 24 h after treatment. Repeated daily BPN injections for 6 days did not produce tolerance to these behavioral effects. nor-BNI produced a similar antidepressant-like response in the FST 24 h post-injection but morphine and desipramine were ineffective. BPN (0.25 mg/kg) did not alter DA levels when given alone but prevented the KOR agonist U50,488 from reducing DA levels.

conclusionsAcute and subchronic treatment with BPN produced antidepressant and anxiolytic-like responses in mice at doses that engage KORs. These studies support the clinical evidence that BPN may be a novel rapid-acting antidepressant medication and provides rodent models for investigating associated neurochemical mechanisms.

Indexed as

AnimalsAnti-Anxiety AgentsAntidepressive AgentsBehavior, AnimalBuprenorphineDepressionDesipramineDopamineMaleMiceMice, Inbred C57BLMotor ActivityNaltrexoneNarcoticsNucleus AccumbensRats, Sprague-DawleyAnti-Anxiety AgentsAntidepressive AgentsBuprenorphineDesipramineDopamineNaltrexoneNarcoticsnorbinaltorphimineReceptors, Opioid, kappa

Identifiers

PMID25178815
PMCPMC4326609
OpenAlexW1972357973

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.